These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9285311

  • 1. The effect of alternate-day low dose prednisolone on bone age in children with steroid dependent nephrotic syndrome.
    Bircan Z, Soran M, Yildirim I, Doğan M, Sahin A, Bilici A, Danaci M.
    Int Urol Nephrol; 1997; 29(3):357-61. PubMed ID: 9285311
    [Abstract] [Full Text] [Related]

  • 2. Alternate-day steroids affect carpal maturation more than radius, ulna and short bones.
    Polito C, Greco N, Opallo A, Cimmaruta E, La Manna A.
    Pediatr Nephrol; 1994 Aug; 8(4):480-2. PubMed ID: 7947042
    [Abstract] [Full Text] [Related]

  • 3. The effect of alternate-day low-dose prednisolone on bone age in children with steroid-dependent nephrotic syndrome.
    Bircan Z, Soran M, Yildirim I, Dogan M, Sahin A, Bilici A, Danaci M.
    Pediatr Nephrol; 1996 Jun; 10(3):397-8. PubMed ID: 8792414
    [No Abstract] [Full Text] [Related]

  • 4. Automatic bone age assessment based on intelligent algorithms and comparison with TW3 method.
    Liu J, Qi J, Liu Z, Ning Q, Luo X.
    Comput Med Imaging Graph; 2008 Dec; 32(8):678-84. PubMed ID: 18835130
    [Abstract] [Full Text] [Related]

  • 5. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J, Grundy N, Trompeter R, Tullus K.
    Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
    [Abstract] [Full Text] [Related]

  • 6. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 7. Advanced RUS and normal carpal bone age in childhood obesity.
    Polito C, Di Toro A, Collini R, Cimmaruta E, D'Alfonso C, Del Giudice G.
    Int J Obes Relat Metab Disord; 1995 Jul; 19(7):506-7. PubMed ID: 8520642
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA, Esezobor CI, Lesi FE.
    Pan Afr Med J; 2016 Jul; 25():258. PubMed ID: 28293374
    [Abstract] [Full Text] [Related]

  • 9. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
    Bak M, Serdaroglu E, Guclu R.
    Pediatr Nephrol; 2006 Mar 10; 21(3):350-4. PubMed ID: 16382319
    [Abstract] [Full Text] [Related]

  • 11. [Reference values of differences between TW3-C RUS and TW3-C Carpal bone ages of children from five cities of China].
    Zhang SY, Liu LJ, Han YS, Liu G, Ma ZG, Shen XZ, Xu RL, Hua JQ.
    Zhonghua Er Ke Za Zhi; 2008 Nov 10; 46(11):851-5. PubMed ID: 19099904
    [Abstract] [Full Text] [Related]

  • 12. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
    Arch Dis Child; 2007 Jul 10; 92(7):585-8. PubMed ID: 17284479
    [Abstract] [Full Text] [Related]

  • 13. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
    Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
    Mymensingh Med J; 2014 Apr 10; 23(2):261-7. PubMed ID: 24858152
    [Abstract] [Full Text] [Related]

  • 14. Increased steroid responsiveness of young children with nephrotic syndrome in Nigeria.
    Asinobi AO, Gbadegesin RA, Ogunkunle OO.
    Ann Trop Paediatr; 2005 Sep 10; 25(3):199-203. PubMed ID: 16156985
    [Abstract] [Full Text] [Related]

  • 15. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
    Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
    Kidney Int; 2015 Jan 10; 87(1):217-24. PubMed ID: 25029428
    [Abstract] [Full Text] [Related]

  • 16. Long-term cyclosporin in steroid-dependent nephrotic syndrome.
    Yoshikawa N, Tanaka R, Kitano Y, Nakamura H, Ito H.
    Contrib Nephrol; 1995 Jan 10; 114():19-27. PubMed ID: 7587196
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration?
    Hodson EM, Craig JC.
    J Am Soc Nephrol; 2013 Jan 10; 24(1):7-9. PubMed ID: 23243214
    [No Abstract] [Full Text] [Related]

  • 18. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P.
    Pediatr Nephrol; 1992 Nov 10; 6(6):522. PubMed ID: 1482637
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Kurupong T, Chaiyapak T, Piyaphanee N, Pattaragarn A, Sumboonnanonda A.
    J Med Assoc Thai; 2013 Jan 10; 96(1):33-40. PubMed ID: 23720975
    [Abstract] [Full Text] [Related]

  • 20. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
    Abeyagunawardena AS, Trompeter RS.
    Arch Dis Child; 2008 Mar 10; 93(3):226-8. PubMed ID: 17573408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.